Corvus hawaiiensis isolate bCorHaw1 chromosome 23, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036368.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC125337413, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125337413, transcript variant X2
uncharacterized LOC125337413, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125337442, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125337442, transcript variant X1
YTH N6-methyladenosine RNA binding protein 2, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
YTH N6-methyladenosine RNA binding protein 2, transcript variant X2
YTH domain-containing family protein 2 isoform X1
YTH domain-containing family protein 2 isoform X2
glucocorticoid modulatory element binding protein 1, transcript variant X1
glucocorticoid modulatory element binding protein 1, transcript variant X2
glucocorticoid modulatory element-binding protein 1 isoform X1
glucocorticoid modulatory element-binding protein 1 isoform X2
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X2
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X6
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X3
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X1
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X4
discoidin, CUB and LCCL domain-containing protein 1-like isoform X1
discoidin, CUB and LCCL domain-containing protein 1-like isoform X4
discoidin, CUB and LCCL domain-containing protein 1-like isoform X3
discoidin, CUB and LCCL domain-containing protein 1-like isoform X2
discoidin, CUB and LCCL domain-containing protein 2-like isoform X6
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X5
discoidin, CUB and LCCL domain-containing protein 1-like isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
TATA-box binding protein associated factor 12, transcript variant X1
TATA-box binding protein associated factor 12, transcript variant X2
TATA-box binding protein associated factor 12, transcript variant X3
transcription initiation factor TFIID subunit 12 isoform X3
transcription initiation factor TFIID subunit 12 isoform X1
transcription initiation factor TFIID subunit 12 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ras-related protein Rab-39B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125337490, transcript variant X5
uncharacterized LOC125337490, transcript variant X6
uncharacterized LOC125337490, transcript variant X3
uncharacterized LOC125337490, transcript variant X4
uncharacterized LOC125337490, transcript variant X2
uncharacterized LOC125337490, transcript variant X9
uncharacterized LOC125337490, transcript variant X8
uncharacterized LOC125337490, transcript variant X7
uncharacterized LOC125337490, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00608
COORDINATES: nucleotide motif:Rfam:12.0:RF00420
COORDINATES: nucleotide motif:Rfam:12.0:RF00405
small nucleolar RNA SNORA16B/SNORA16A family
COORDINATES: nucleotide motif:Rfam:12.0:RF00190
tRNA selenocysteine 1 associated protein 1, transcript variant X1
tRNA selenocysteine 1 associated protein 1, transcript variant X2
tRNA selenocysteine 1 associated protein 1, transcript variant X3
tRNA selenocysteine 1-associated protein 1 isoform X1
tRNA selenocysteine 1-associated protein 1 isoform X2
uncharacterized LOC125337434, transcript variant X3
uncharacterized LOC125337434, transcript variant X1
uncharacterized LOC125337434, transcript variant X4
uncharacterized LOC125337434, transcript variant X2
CCN family member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
CCN family member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
erythrocyte membrane protein band 4.1, transcript variant X2
erythrocyte membrane protein band 4.1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
erythrocyte membrane protein band 4.1, transcript variant X1
erythrocyte membrane protein band 4.1, transcript variant X4
erythrocyte membrane protein band 4.1, transcript variant X3
erythrocyte membrane protein band 4.1, transcript variant X6
erythrocyte membrane protein band 4.1, transcript variant X7
erythrocyte membrane protein band 4.1, transcript variant X8
erythrocyte membrane protein band 4.1, transcript variant X13
erythrocyte membrane protein band 4.1, transcript variant X14
erythrocyte membrane protein band 4.1, transcript variant X15
erythrocyte membrane protein band 4.1, transcript variant X16
erythrocyte membrane protein band 4.1, transcript variant X5
erythrocyte membrane protein band 4.1, transcript variant X22
erythrocyte membrane protein band 4.1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
erythrocyte membrane protein band 4.1, transcript variant X9
erythrocyte membrane protein band 4.1, transcript variant X10
erythrocyte membrane protein band 4.1, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
erythrocyte membrane protein band 4.1, transcript variant X11
erythrocyte membrane protein band 4.1, transcript variant X12
erythrocyte membrane protein band 4.1, transcript variant X21
erythrocyte membrane protein band 4.1, transcript variant X17
erythrocyte membrane protein band 4.1, transcript variant X18
erythrocyte membrane protein band 4.1, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
lethal(3)malignant brain tumor-like protein 3, transcript variant X3
lethal(3)malignant brain tumor-like protein 3, transcript variant X1
lethal(3)malignant brain tumor-like protein 3, transcript variant X2
lethal(3)malignant brain tumor-like protein 3, transcript variant X5
lethal(3)malignant brain tumor-like protein 3, transcript variant X4
lethal(3)malignant brain tumor-like protein 3, transcript variant X6
lethal(3)malignant brain tumor-like protein 3, transcript variant X7
lethal(3)malignant brain tumor-like protein 4 isoform X4
lethal(3)malignant brain tumor-like protein 3 isoform X3
lethal(3)malignant brain tumor-like protein 1 isoform X6
lethal(3)malignant brain tumor-like protein 3 isoform X5
lethal(3)malignant brain tumor-like protein 4 isoform X2
lethal(3)malignant brain tumor-like protein 4 isoform X1
lethal(3)malignant brain tumor-like protein 3 isoform X7
lethal(3)malignant brain tumor-like protein 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
lethal(3)malignant brain tumor-like protein 3 isoform X8
serine and arginine rich splicing factor 4
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X4
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X1
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X2
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X3
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X1
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X2
protein tyrosine phosphatase receptor type U, transcript variant X3
protein tyrosine phosphatase receptor type U, transcript variant X1
protein tyrosine phosphatase receptor type U, transcript variant X4
protein tyrosine phosphatase receptor type U, transcript variant X5
protein tyrosine phosphatase receptor type U, transcript variant X2
protein tyrosine phosphatase receptor type U, transcript variant X6
receptor-type tyrosine-protein phosphatase U isoform X3
receptor-type tyrosine-protein phosphatase U isoform X1
receptor-type tyrosine-protein phosphatase U isoform X4
receptor-type tyrosine-protein phosphatase U isoform X5
receptor-type tyrosine-protein phosphatase U isoform X2
receptor-type tyrosine-protein phosphatase U isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lysosomal protein transmembrane 5, transcript variant X1
lysosomal protein transmembrane 5, transcript variant X2
lysosomal-associated transmembrane protein 5 isoform X2
lysosomal-associated transmembrane protein 5 isoform X1
uncharacterized LOC125337554, transcript variant X1
uncharacterized LOC125337554, transcript variant X2
pumilio RNA binding family member 1, transcript variant X4
pumilio RNA binding family member 1, transcript variant X2
pumilio RNA binding family member 1, transcript variant X7
pumilio RNA binding family member 1, transcript variant X6
pumilio RNA binding family member 1, transcript variant X5
pumilio RNA binding family member 1, transcript variant X3
pumilio RNA binding family member 1, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00188
sodium/potassium transporting ATPase interacting 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1
small nuclear ribonucleoprotein U5 subunit 40
U5 small nuclear ribonucleoprotein 40 kDa protein
zinc finger CCHC-type containing 17, transcript variant X1
zinc finger CCHC-type containing 17, transcript variant X2
zinc finger CCHC-type containing 17, transcript variant X3
cAMP-dependent protein kinase inhibitor beta-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription factor HIVEP3-like
Scm polycomb group protein homolog 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
Scm polycomb group protein homolog 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Scm polycomb group protein homolog 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
Scm polycomb group protein homolog 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Scm polycomb group protein homolog 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Scm polycomb group protein homolog 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Scm polycomb group protein homolog 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 8
nuclear inhibitor of protein phosphatase 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00553
sphingomyelin phosphodiesterase acid like 3B, transcript variant X1
sphingomyelin phosphodiesterase acid like 3B, transcript variant X2
acid sphingomyelinase-like phosphodiesterase 3b isoform X1
acid sphingomyelinase-like phosphodiesterase 3b isoform X2
replication protein A2, transcript variant X1
replication protein A2, transcript variant X2
replication protein A 32 kDa subunit isoform X1
replication protein A 32 kDa subunit isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 3, transcript variant X6
EYA transcriptional coactivator and phosphatase 3, transcript variant X5
EYA transcriptional coactivator and phosphatase 3, transcript variant X4
EYA transcriptional coactivator and phosphatase 3, transcript variant X1
EYA transcriptional coactivator and phosphatase 3, transcript variant X3
EYA transcriptional coactivator and phosphatase 3, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: platelet-activating factor receptor
DnaJ heat shock protein family (Hsp40) member C8
ATP synthase inhibitory factor subunit 1
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R isoform X2
5-hydroxytryptamine receptor 1D, transcript variant X1
5-hydroxytryptamine receptor 1D, transcript variant X10
5-hydroxytryptamine receptor 1D, transcript variant X6
5-hydroxytryptamine receptor 1D, transcript variant X8
5-hydroxytryptamine receptor 1D, transcript variant X11
5-hydroxytryptamine receptor 1D, transcript variant X14
5-hydroxytryptamine receptor 1D, transcript variant X7
5-hydroxytryptamine receptor 1D, transcript variant X12
5-hydroxytryptamine receptor 1D, transcript variant X16
5-hydroxytryptamine receptor 1D, transcript variant X13
5-hydroxytryptamine receptor 1D, transcript variant X15
5-hydroxytryptamine receptor 1D, transcript variant X3
5-hydroxytryptamine receptor 1D, transcript variant X9
5-hydroxytryptamine receptor 1D, transcript variant X18
5-hydroxytryptamine receptor 1D, transcript variant X5
5-hydroxytryptamine receptor 1D, transcript variant X19
5-hydroxytryptamine receptor 1D, transcript variant X2
5-hydroxytryptamine receptor 1D, transcript variant X4
5-hydroxytryptamine receptor 1D, transcript variant X17
leucine zipper protein 1, transcript variant X5
leucine zipper protein 1, transcript variant X1
leucine zipper protein 1, transcript variant X3
leucine zipper protein 1, transcript variant X2
leucine zipper protein 1, transcript variant X4
lysine demethylase 1A, transcript variant X2
lysine demethylase 1A, transcript variant X1
lysine-specific histone demethylase 1A isoform X2
lysine-specific histone demethylase 1A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
NFKB inhibitor delta, transcript variant X1
NFKB inhibitor delta, transcript variant X4
NFKB inhibitor delta, transcript variant X6
NFKB inhibitor delta, transcript variant X2
NFKB inhibitor delta, transcript variant X3
NFKB inhibitor delta, transcript variant X5
gap junction protein alpha 9, transcript variant X1
gap junction protein alpha 9, transcript variant X2
MYC binding protein, transcript variant X1
MYC binding protein, transcript variant X3
MYC binding protein, transcript variant X2
POU domain, class 3, transcription factor 1
UTP11 small subunit processome component
probable U3 small nucleolar RNA-associated protein 11
four and a half LIM domains 3, transcript variant X3
four and a half LIM domains 3, transcript variant X4
four and a half LIM domains 3, transcript variant X1
four and a half LIM domains 3, transcript variant X2
four and a half LIM domains protein 3 isoform X1
four and a half LIM domains protein 3 isoform X2
four and a half LIM domains protein 3 isoform X3
inositol polyphosphate-5-phosphatase B, transcript variant X1
inositol polyphosphate-5-phosphatase B, transcript variant X2
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X1
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X2
inositol polyphosphate-5-phosphatase B, transcript variant X3
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X3
inositol polyphosphate-5-phosphatase B, transcript variant X4
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X4
metal regulatory transcription factor 1, transcript variant X1
metal regulatory transcription factor 1, transcript variant X2
metal regulatory transcription factor 1 isoform X1
metal regulatory transcription factor 1 isoform X2
yrdC N6-threonylcarbamoyltransferase domain containing
yrdC domain-containing protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C1orf109 homolog
dynein axonemal light intermediate chain 1
axonemal dynein light intermediate polypeptide 1
MYST/Esa1 associated factor 6, transcript variant X4
MYST/Esa1 associated factor 6, transcript variant X3
MYST/Esa1 associated factor 6, transcript variant X1
MYST/Esa1 associated factor 6, transcript variant X5
MYST/Esa1 associated factor 6, transcript variant X2
chromatin modification-related protein MEAF6 isoform X1
chromatin modification-related protein MEAF6 isoform X2
uncharacterized LOC125337316, transcript variant X2
uncharacterized LOC125337316, transcript variant X1
uncharacterized LOC125337316, transcript variant X3
uncharacterized LOC125337316, transcript variant X4
uncharacterized protein LOC125337316 isoform X2
uncharacterized protein LOC125337316 isoform X1
uncharacterized protein LOC125337316 isoform X3
uncharacterized protein LOC125337316 isoform X4
glutamate ionotropic receptor kainate type subunit 3
glutamate receptor ionotropic, kainate 3
colony stimulating factor 3 receptor, transcript variant X1
colony stimulating factor 3 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
granulocyte colony-stimulating factor receptor isoform X1
granulocyte colony-stimulating factor receptor isoform X2
28S ribosomal protein S15, mitochondrial
organic solute carrier partner 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
organic solute carrier partner 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
U7 snRNA-associated Sm-like protein LSm10
serine/threonine kinase 40, transcript variant X2
serine/threonine kinase 40, transcript variant X3
serine/threonine kinase 40, transcript variant X4
serine/threonine kinase 40, transcript variant X1
SH3 domain-containing kinase-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
SH3 domain-containing kinase-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SH3 domain-containing kinase-binding protein 1-like isoform X1
SH3 domain-containing kinase-binding protein 1-like isoform X2
thyroid hormone receptor associated protein 3, transcript variant X5
thyroid hormone receptor associated protein 3, transcript variant X6
thyroid hormone receptor associated protein 3, transcript variant X7
thyroid hormone receptor associated protein 3, transcript variant X1
thyroid hormone receptor associated protein 3, transcript variant X4
thyroid hormone receptor associated protein 3, transcript variant X3
thyroid hormone receptor associated protein 3, transcript variant X2
thyroid hormone receptor-associated protein 3 isoform X3
thyroid hormone receptor-associated protein 3 isoform X2
thyroid hormone receptor-associated protein 3 isoform X1
thyroid hormone receptor associated protein 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
thyroid hormone receptor-associated protein 3 isoform X4
MAP7 domain containing 1, transcript variant X6
MAP7 domain containing 1, transcript variant X7
MAP7 domain containing 1, transcript variant X8
MAP7 domain containing 1, transcript variant X4
MAP7 domain containing 1, transcript variant X2
MAP7 domain containing 1, transcript variant X3
MAP7 domain containing 1, transcript variant X1
MAP7 domain containing 1, transcript variant X5
MAP7 domain-containing protein 1 isoform X7
MAP7 domain-containing protein 1 isoform X4
MAP7 domain-containing protein 1 isoform X2
MAP7 domain-containing protein 1 isoform X3
MAP7 domain-containing protein 1 isoform X1
MAP7 domain-containing protein 1 isoform X5
MAP7 domain-containing protein 1 isoform X6
probable beta-D-xylosidase 2, transcript variant X2
probable beta-D-xylosidase 2, transcript variant X1
trafficking protein particle complex subunit 3, transcript variant X2
trafficking protein particle complex subunit 3, transcript variant X1
trafficking protein particle complex subunit 3 isoform X1
trafficking protein particle complex subunit 3 isoform X2
collagen type VIII alpha 2 chain, transcript variant X3
collagen type VIII alpha 2 chain, transcript variant X2
collagen type VIII alpha 2 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein argonaute-1, transcript variant X2
protein argonaute-1, transcript variant X1
protein argonaute-4, transcript variant X1
protein argonaute-4, transcript variant X2
transcription factor AP-2 epsilon, transcript variant X2
transcription factor AP-2 epsilon, transcript variant X1
transcription factor AP-2-epsilon isoform X2
transcription factor AP-2-epsilon isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
dyslexia-associated protein KIAA0319-like protein homolog isoform X1
dyslexia-associated protein KIAA0319-like protein homolog isoform X2
interferon alpha-inducible protein 27-like protein 2, transcript variant X1
interferon alpha-inducible protein 27-like protein 2B isoform X1
interferon alpha-inducible protein 27-like protein 2, transcript variant X17
interferon alpha-inducible protein 27-like protein 2, transcript variant X16
interferon alpha-inducible protein 27-like protein 2, transcript variant X7
interferon alpha-inducible protein 27-like protein 2, transcript variant X12
interferon alpha-inducible protein 27-like protein 2, transcript variant X14
interferon alpha-inducible protein 27-like protein 2, transcript variant X5
interferon alpha-inducible protein 27-like protein 2, transcript variant X4
interferon alpha-inducible protein 27-like protein 2, transcript variant X3
interferon alpha-inducible protein 27-like protein 2, transcript variant X11
interferon alpha-inducible protein 27-like protein 2, transcript variant X13
interferon alpha-inducible protein 27-like protein 2, transcript variant X9
interferon alpha-inducible protein 27-like protein 2, transcript variant X10
interferon alpha-inducible protein 27-like protein 2, transcript variant X15
interferon alpha-inducible protein 27-like protein 2, transcript variant X6
interferon alpha-inducible protein 27-like protein 2, transcript variant X8
interferon alpha-inducible protein 27-like protein 2 isoform X3
interferon alpha-inducible protein 27-like protein 2, transcript variant X2
interferon alpha-inducible protein 27-like protein 2 isoform X2
interferon alpha-inducible protein 27-like protein 2 isoform X4
zinc finger MYM-type containing 4, transcript variant X3
zinc finger MYM-type containing 4, transcript variant X2
zinc finger MYM-type containing 4, transcript variant X7
zinc finger MYM-type containing 4, transcript variant X6
zinc finger MYM-type containing 4, transcript variant X5
zinc finger MYM-type containing 4, transcript variant X4
zinc finger MYM-type containing 4, transcript variant X1
zinc finger MYM-type protein 4 isoform X7
zinc finger MYM-type protein 4 isoform X6
zinc finger MYM-type protein 4 isoform X5
zinc finger MYM-type protein 4 isoform X2
zinc finger MYM-type protein 4 isoform X4
zinc finger MYM-type protein 4 isoform X1
zinc finger MYM-type protein 4 isoform X3
splicing factor proline and glutamine rich, transcript variant X4
splicing factor proline and glutamine rich, transcript variant X3
splicing factor proline and glutamine rich, transcript variant X1
splicing factor proline and glutamine rich, transcript variant X2
splicing factor, proline- and glutamine-rich isoform X2
splicing factor, proline- and glutamine-rich isoform X1
platelet-activating factor receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
DLG associated protein 3, transcript variant X1
DLG associated protein 3, transcript variant X2
disks large-associated protein 3 isoform X1
disks large-associated protein 3 isoform X2
gap junction protein alpha 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
gap junction protein alpha 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
gap junction beta-3 protein-like, transcript variant X6
gap junction beta-3 protein-like, transcript variant X2
gap junction beta-3 protein-like, transcript variant X4
gap junction beta-3 protein-like, transcript variant X5
gap junction beta-3 protein-like, transcript variant X1
gap junction beta-3 protein-like, transcript variant X3
gap junction beta-3 protein-like, transcript variant X7
gap junction beta-3 protein-like isoform X2
gap junction beta-3 protein-like isoform X1
gap junction beta-5 protein-like, transcript variant X1
gap junction beta-5 protein-like, transcript variant X3
gap junction beta-5 protein-like, transcript variant X2
gap junction beta-5 protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: CUB and sushi domain-containing protein 2
collagen type IX alpha 2 chain, transcript variant X1
collagen type IX alpha 2 chain, transcript variant X2
stromal membrane-associated protein 2 isoform X1
stromal membrane-associated protein 2 isoform X2
regulating synaptic membrane exocytosis 3, transcript variant X3
regulating synaptic membrane exocytosis 3, transcript variant X4
regulating synaptic membrane exocytosis 3, transcript variant X1
regulating synaptic membrane exocytosis 3, transcript variant X2
regulating synaptic membrane exocytosis protein 3
nuclear transcription factor Y subunit gamma, transcript variant X2
nuclear transcription factor Y subunit gamma, transcript variant X3
nuclear transcription factor Y subunit gamma, transcript variant X4
nuclear transcription factor Y subunit gamma, transcript variant X1
nuclear transcription factor Y subunit gamma isoform X1
nuclear transcription factor Y subunit gamma isoform X2
nuclear transcription factor Y subunit gamma isoform X3
potassium voltage-gated channel subfamily Q member 4
potassium voltage-gated channel subfamily KQT member 4
tubulointerstitial nephritis antigen like 1, transcript variant X1
tubulointerstitial nephritis antigen-like isoform X1
tubulointerstitial nephritis antigen like 1, transcript variant X3
tubulointerstitial nephritis antigen like 1, transcript variant X2
tubulointerstitial nephritis antigen-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-1(XVI) chain
adhesion G protein-coupled receptor B2, transcript variant X10
adhesion G protein-coupled receptor B2, transcript variant X11
adhesion G protein-coupled receptor B2, transcript variant X4
adhesion G protein-coupled receptor B2, transcript variant X2
adhesion G protein-coupled receptor B2, transcript variant X3
adhesion G protein-coupled receptor B2, transcript variant X1
adhesion G protein-coupled receptor B2, transcript variant X5
adhesion G protein-coupled receptor B2, transcript variant X8
adhesion G protein-coupled receptor B2, transcript variant X9
adhesion G protein-coupled receptor B2, transcript variant X6
adhesion G protein-coupled receptor B2, transcript variant X7
adhesion G protein-coupled receptor B2 isoform X9
adhesion G protein-coupled receptor B2 isoform X8
adhesion G protein-coupled receptor B2 isoform X5
adhesion G protein-coupled receptor B2 isoform X2
adhesion G protein-coupled receptor B2 isoform X3
adhesion G protein-coupled receptor B2 isoform X4
adhesion G protein-coupled receptor B2 isoform X1
adhesion G protein-coupled receptor B2 isoform X6
adhesion G protein-coupled receptor B2 isoform X7
adhesion G protein-coupled receptor B2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
adhesion G protein-coupled receptor B2 isoform X10
uncharacterized protein C13orf46 homolog
uncharacterized LOC125337361, transcript variant X1
uncharacterized LOC125337361, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125337361, transcript variant X4
uncharacterized LOC125337361, transcript variant X2
uncharacterized LOC125337361, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
KH RNA binding domain containing, signal transduction associated 1
KH domain-containing, RNA-binding, signal transduction-associated protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane protein 39B
LCK proto-oncogene, Src family tyrosine kinase
family with sequence similarity 167 member B, transcript variant X1
family with sequence similarity 167 member B, transcript variant X2
myotubularin-related protein 9-like, transcript variant X3
myotubularin-related protein 9-like, transcript variant X2
myotubularin-related protein 9-like, transcript variant X1
myotubularin-related protein 9-like isoform X1
myotubularin-related protein 9-like isoform X2
eukaryotic translation initiation factor 3 subunit I
transmembrane protein 234, transcript variant X2
transmembrane protein 234, transcript variant X1
feruloyl esterase B-like, transcript variant X3
feruloyl esterase B-like, transcript variant X4
feruloyl esterase B-like, transcript variant X9
feruloyl esterase B-like, transcript variant X5
feruloyl esterase B-like, transcript variant X2
feruloyl esterase B-like, transcript variant X1
feruloyl esterase B-like, transcript variant X7
feruloyl esterase B-like, transcript variant X8
feruloyl esterase B-like, transcript variant X13
feruloyl esterase B-like, transcript variant X6
feruloyl esterase B-like, transcript variant X10
feruloyl esterase B-like, transcript variant X12
feruloyl esterase B-like, transcript variant X11
uncharacterized protein LOC125337252 isoform X3
uncharacterized protein LOC125337252 isoform X8
uncharacterized protein LOC125337252 isoform X2
uncharacterized protein LOC125337252 isoform X1
uncharacterized protein LOC125337252 isoform X5
uncharacterized protein LOC125337252 isoform X9
uncharacterized protein LOC125337252 isoform X7
uncharacterized protein LOC125337252 isoform X6
uncharacterized protein LOC125337252 isoform X10
feruloyl esterase B-like, transcript variant X14
uncharacterized protein LOC125337252 isoform X11
coiled-coil domain-containing protein 28B-like, transcript variant X1
coiled-coil domain-containing protein 28B-like, transcript variant X2
coiled-coil domain-containing protein 28B-like, transcript variant X4
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like isoform X2
IQ domain-containing protein C-like isoform X4
coiled-coil domain-containing protein 28B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
translation initiation factor IF-2-like isoform X3
coiled-coil domain-containing protein 28B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
coiled-coil domain-containing protein 28B-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 28B-like isoform X6
coiled-coil domain-containing protein 28B-like isoform X8
coiled-coil domain-containing protein 28B-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized PE-PGRS family protein PE_PGRS24-like isoform X7
coiled-coil domain-containing protein 28B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
coiled-coil domain-containing protein 28B-like isoform X5
zinc finger and BTB domain containing 8B, transcript variant X2
zinc finger and BTB domain containing 8B, transcript variant X1
zinc finger and BTB domain-containing protein 8B
zinc finger and BTB domain containing 8A, transcript variant X4
zinc finger and BTB domain containing 8A, transcript variant X1
zinc finger and BTB domain containing 8A, transcript variant X2
zinc finger and BTB domain containing 8A, transcript variant X3
zinc finger and BTB domain-containing protein 8A
zinc finger and BTB domain-containing protein 8A-like, transcript variant X2
zinc finger and BTB domain-containing protein 8A-like, transcript variant X1
zinc finger and BTB domain-containing protein 8A-like, transcript variant X4
zinc finger and BTB domain-containing protein 8A-like, transcript variant X3
zinc finger and BTB domain-containing protein 8A-like
zinc finger and BTB domain containing 8 opposite strand, transcript variant X3
zinc finger and BTB domain containing 8 opposite strand, transcript variant X2
zinc finger and BTB domain containing 8 opposite strand, transcript variant X1
zinc finger and BTB domain containing 8 opposite strand, transcript variant X4
RB binding protein 4, chromatin remodeling factor, transcript variant X1
RB binding protein 4, chromatin remodeling factor, transcript variant X2
histone-binding protein RBBP4 isoform X1
histone-binding protein RBBP4 isoform X2
RB binding protein 4, chromatin remodeling factor, transcript variant X3
histone-binding protein RBBP4 isoform X3
syncoilin, intermediate filament protein, transcript variant X2
syncoilin, intermediate filament protein, transcript variant X1
KIAA1522 ortholog, transcript variant X1
uncharacterized protein KIAA1522 homolog isoform X1
KIAA1522 ortholog, transcript variant X2
uncharacterized protein KIAA1522 homolog isoform X2
uncharacterized LOC125337443, transcript variant X1
uncharacterized LOC125337443, transcript variant X2
uncharacterized protein LOC125337443 isoform X1
uncharacterized protein LOC125337443 isoform X2
fibronectin type III domain containing 5
fibronectin type III domain-containing protein 5
neuron-specific calcium-binding protein hippocalcin
transmembrane protein 54, transcript variant X4
transmembrane protein 54, transcript variant X3
transmembrane protein 54, transcript variant X2
transmembrane protein 54, transcript variant X1
adenylate kinase 2, transcript variant X2
adenylate kinase 2, mitochondrial isoform X2
adenylate kinase 2, transcript variant X1
adenylate kinase 2, mitochondrial isoform X1
antizyme inhibitor 2, transcript variant X1
antizyme inhibitor 2, transcript variant X2
antizyme inhibitor 2, transcript variant X3
antizyme inhibitor 2, transcript variant X4
NADH:ubiquinone oxidoreductase subunit S5
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5
microtubule actin crosslinking factor 1, transcript variant X15
microtubule actin crosslinking factor 1, transcript variant X16
microtubule actin crosslinking factor 1, transcript variant X28
microtubule actin crosslinking factor 1, transcript variant X30
microtubule actin crosslinking factor 1, transcript variant X26
microtubule actin crosslinking factor 1, transcript variant X25
microtubule actin crosslinking factor 1, transcript variant X29
microtubule actin crosslinking factor 1, transcript variant X27
microtubule actin crosslinking factor 1, transcript variant X24
microtubule-actin cross-linking factor 1 isoform X15
microtubule-actin cross-linking factor 1 isoform X16
microtubule-actin cross-linking factor 1 isoform X28
microtubule-actin cross-linking factor 1 isoform X30
microtubule-actin cross-linking factor 1 isoform X26
microtubule-actin cross-linking factor 1 isoform X25
microtubule-actin cross-linking factor 1 isoform X29
microtubule-actin cross-linking factor 1 isoform X24
microtubule-actin cross-linking factor 1 isoform X27
microtubule actin crosslinking factor 1, transcript variant X20
microtubule-actin cross-linking factor 1 isoform X20
microtubule actin crosslinking factor 1, transcript variant X19
microtubule-actin cross-linking factor 1 isoform X19
microtubule actin crosslinking factor 1, transcript variant X21
microtubule actin crosslinking factor 1, transcript variant X31
microtubule-actin cross-linking factor 1 isoform X21
microtubule-actin cross-linking factor 1 isoform X31
microtubule actin crosslinking factor 1, transcript variant X7
microtubule actin crosslinking factor 1, transcript variant X12
microtubule actin crosslinking factor 1, transcript variant X9
microtubule actin crosslinking factor 1, transcript variant X18
microtubule actin crosslinking factor 1, transcript variant X1
microtubule actin crosslinking factor 1, transcript variant X10
microtubule actin crosslinking factor 1, transcript variant X2
microtubule actin crosslinking factor 1, transcript variant X6
microtubule actin crosslinking factor 1, transcript variant X11
microtubule actin crosslinking factor 1, transcript variant X5
microtubule actin crosslinking factor 1, transcript variant X8
microtubule actin crosslinking factor 1, transcript variant X13
microtubule actin crosslinking factor 1, transcript variant X17
microtubule actin crosslinking factor 1, transcript variant X14
microtubule actin crosslinking factor 1, transcript variant X4
microtubule actin crosslinking factor 1, transcript variant X3
microtubule actin crosslinking factor 1, transcript variant X23
microtubule-actin cross-linking factor 1 isoform X1
microtubule-actin cross-linking factor 1 isoform X10
microtubule-actin cross-linking factor 1 isoform X7
microtubule-actin cross-linking factor 1 isoform X2
microtubule-actin cross-linking factor 1 isoform X6
microtubule-actin cross-linking factor 1 isoform X11
microtubule-actin cross-linking factor 1 isoform X12
microtubule-actin cross-linking factor 1 isoform X5
microtubule-actin cross-linking factor 1 isoform X8
microtubule-actin cross-linking factor 1 isoform X9
microtubule-actin cross-linking factor 1 isoform X13
microtubule-actin cross-linking factor 1 isoform X18
microtubule-actin cross-linking factor 1 isoform X17
microtubule-actin cross-linking factor 1 isoform X14
microtubule-actin cross-linking factor 1 isoform X4
microtubule-actin cross-linking factor 1 isoform X23
microtubule-actin cross-linking factor 1 isoform X3
microtubule actin crosslinking factor 1, transcript variant X22
microtubule-actin cross-linking factor 1 isoform X22
poly(A) binding protein cytoplasmic 4, transcript variant X1
poly(A) binding protein cytoplasmic 4, transcript variant X4
poly(A) binding protein cytoplasmic 4, transcript variant X2
poly(A) binding protein cytoplasmic 4, transcript variant X3
polyadenylate-binding protein 4 isoform X3
polyadenylate-binding protein 4 isoform X1
polyadenylate-binding protein 4 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00431
hes related family bHLH transcription factor with YRPW motif like
hairy/enhancer-of-split related with YRPW motif-like protein
CYFIP-related Rac1 interactor A-like, transcript variant X3
CYFIP-related Rac1 interactor A-like, transcript variant X2
CYFIP-related Rac1 interactor A-like isoform X3
CYFIP-related Rac1 interactor A-like, transcript variant X1
CYFIP-related Rac1 interactor A-like isoform X1
CYFIP-related Rac1 interactor A-like isoform X2
tRNA isopentenyltransferase 1, transcript variant X1
tRNA dimethylallyltransferase isoform X1
tRNA isopentenyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
tRNA dimethylallyltransferase isoform X2
MYCL proto-oncogene, bHLH transcription factor
major facilitator superfamily domain containing 2A
sodium-dependent lysophosphatidylcholine symporter 1
cyclase associated actin cytoskeleton regulatory protein 1
palmitoyl-protein thioesterase 1, transcript variant X1
palmitoyl-protein thioesterase 1, transcript variant X2
palmitoyl-protein thioesterase 1 isoform X1
palmitoyl-protein thioesterase 1 isoform X2
kelch-like protein 31, transcript variant X2
kelch-like protein 31, transcript variant X1
kelch-like protein 31, transcript variant X3
lysophospholipase 2, transcript variant X2
lysophospholipase 2, transcript variant X3
lysophospholipase 2, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X3
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X2
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X1
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X3
cannabinoid receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cannabinoid receptor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cannabinoid receptor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cannabinoid receptor 2, transcript variant X1
cannabinoid receptor 2, transcript variant X2
proline rich nuclear receptor coactivator 2, transcript variant X1
proline rich nuclear receptor coactivator 2, transcript variant X2
proline-rich nuclear receptor coactivator 2
serine and arginine rich splicing factor 10, transcript variant X2
serine and arginine rich splicing factor 10, transcript variant X4
serine and arginine rich splicing factor 10, transcript variant X1
serine and arginine rich splicing factor 10, transcript variant X6
serine and arginine rich splicing factor 10, transcript variant X5
serine and arginine rich splicing factor 10, transcript variant X3
serine/arginine-rich splicing factor 10 isoform X6
serine/arginine-rich splicing factor 10 isoform X5
serine/arginine-rich splicing factor 10 isoform X4
serine/arginine-rich splicing factor 10 isoform X2
serine/arginine-rich splicing factor 10 isoform X1
serine/arginine-rich splicing factor 10 isoform X3
grainyhead like transcription factor 3, transcript variant X3
grainyhead like transcription factor 3, transcript variant X4
grainyhead like transcription factor 3, transcript variant X5
grainyhead like transcription factor 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
grainyhead like transcription factor 3, transcript variant X7
grainyhead like transcription factor 3, transcript variant X2
grainyhead like transcription factor 3, transcript variant X1
grainyhead-like protein 3 homolog isoform X1
grainyhead-like protein 3 homolog isoform X2
grainyhead-like protein 3 homolog isoform X3
uncharacterized LOC125337551, transcript variant X2
uncharacterized LOC125337551, transcript variant X1
uncharacterized LOC125337551, transcript variant X3
uncharacterized LOC125337551, transcript variant X4
NIPA like domain containing 3, transcript variant X1
NIPA like domain containing 3, transcript variant X2
RCAN family member 3, transcript variant X1
RCAN family member 3, transcript variant X3
RCAN family member 3, transcript variant X2
non-compact myelin associated protein, transcript variant X3
non-compact myelin associated protein, transcript variant X2
noncompact myelin-associated protein isoform X2
non-compact myelin associated protein, transcript variant X1
noncompact myelin-associated protein isoform X1
noncompact myelin-associated protein isoform X3
serine and arginine repetitive matrix 1, transcript variant X1
serine and arginine repetitive matrix 1, transcript variant X3
serine and arginine repetitive matrix 1, transcript variant X2
serine and arginine repetitive matrix 1, transcript variant X5
serine and arginine repetitive matrix 1, transcript variant X8
serine and arginine repetitive matrix 1, transcript variant X10
serine and arginine repetitive matrix 1, transcript variant X4
serine and arginine repetitive matrix 1, transcript variant X9
serine and arginine repetitive matrix 1, transcript variant X6
serine and arginine repetitive matrix 1, transcript variant X11
serine and arginine repetitive matrix 1, transcript variant X7
serine/arginine repetitive matrix protein 1 isoform X1
serine/arginine repetitive matrix protein 1 isoform X3
serine/arginine repetitive matrix protein 1 isoform X6
serine/arginine repetitive matrix protein 1 isoform X8
serine/arginine repetitive matrix protein 1 isoform X2
serine/arginine repetitive matrix protein 1 isoform X7
serine/arginine repetitive matrix protein 1 isoform X4
serine/arginine repetitive matrix protein 1 isoform X9
serine/arginine repetitive matrix protein 1 isoform X5
serine and arginine repetitive matrix 1, transcript variant X12
serine and arginine repetitive matrix 1, transcript variant X13
serine/arginine repetitive matrix protein 1 isoform X10
chloride intracellular channel protein 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: arginine/serine-rich protein 1
transmembrane protein 50A, transcript variant X1
transmembrane protein 50A, transcript variant X2
Rh blood group CcEe antigens, transcript variant X5
Rh blood group CcEe antigens, transcript variant X3
Rh blood group CcEe antigens, transcript variant X2
Rh blood group CcEe antigens, transcript variant X4
Rh blood group CcEe antigens, transcript variant X1
blood group Rh(CE) polypeptide isoform X1
blood group Rh(CE) polypeptide isoform X2
low density lipoprotein receptor adaptor protein 1, transcript variant X1
low density lipoprotein receptor adaptor protein 1, transcript variant X2
low density lipoprotein receptor adapter protein 1 isoform X1
low density lipoprotein receptor adapter protein 1 isoform X2
mannosidase alpha class 1C member 1, transcript variant X1
mannosidase alpha class 1C member 1, transcript variant X2
mannosyl-oligosaccharide 1,2-alpha-mannosidase IC isoform X1
mannosyl-oligosaccharide 1,2-alpha-mannosidase IC isoform X2
mitochondrial fission regulator 1 like, transcript variant X1
mitochondrial fission regulator 1 like, transcript variant X2
mitochondrial fission regulator 1 like, transcript variant X3
mitochondrial fission regulator 1-like isoform X2
mitochondrial fission regulator 1-like isoform X1
progestin and adipoQ receptor family member 7, transcript variant X3
progestin and adipoQ receptor family member 7, transcript variant X1
membrane progestin receptor alpha isoform X1
progestin and adipoQ receptor family member 7, transcript variant X2
progestin and adipoQ receptor family member 7, transcript variant X4
progestin and adipoQ receptor family member 7, transcript variant X7
progestin and adipoQ receptor family member 7, transcript variant X5
progestin and adipoQ receptor family member 7, transcript variant X8
progestin and adipoQ receptor family member 7, transcript variant X6
membrane progestin receptor alpha isoform X2
membrane progestin receptor alpha isoform X3
platelet activating factor acetylhydrolase 2
platelet-activating factor acetylhydrolase 2, cytoplasmic
exostosin like glycosyltransferase 1, transcript variant X2
exostosin like glycosyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase TRIM63
PDLIM1 interacting kinase 1 like, transcript variant X3
PDLIM1 interacting kinase 1 like, transcript variant X2
PDLIM1 interacting kinase 1 like, transcript variant X4
PDLIM1 interacting kinase 1 like, transcript variant X1
family with sequence similarity 110 member D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 110 member D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized protein C1orf232 homolog
connector enhancer of kinase suppressor of Ras 1
centrosomal protein 85, transcript variant X1
centrosomal protein of 85 kDa isoform X1
centrosomal protein 85, transcript variant X2
centrosomal protein 85, transcript variant X3
centrosomal protein of 85 kDa isoform X2
SH3 domain binding glutamate rich protein like 3
SH3 domain-binding glutamic acid-rich-like protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
crystallin beta-gamma domain containing 2
beta/gamma crystallin domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
dehydrodolichyl diphosphate synthase subunit, transcript variant X1
dehydrodolichyl diphosphate synthase subunit, transcript variant X2
dehydrodolichyl diphosphate synthase complex subunit DHDDS
high mobility group nucleosomal binding domain 2
ribosomal protein S6 kinase A1, transcript variant X3
ribosomal protein S6 kinase A1, transcript variant X1
ribosomal protein S6 kinase A1, transcript variant X5
ribosomal protein S6 kinase A1, transcript variant X2
ribosomal protein S6 kinase A1, transcript variant X4
ribosomal protein S6 kinase alpha-1 isoform X1
ribosomal protein S6 kinase alpha-1 isoform X2
ribosomal protein S6 kinase alpha-1 isoform X3
ribosomal protein S6 kinase alpha-1 isoform X4
ribosomal protein S6 kinase alpha-1 isoform X5
ribosomal protein S6 kinase A1, transcript variant X7
ribosomal protein S6 kinase alpha-1 isoform X7
ribosomal protein S6 kinase A1, transcript variant X6
ribosomal protein S6 kinase A1, transcript variant X8
ribosomal protein S6 kinase alpha-1 isoform X6
ribosomal protein S6 kinase alpha-1 isoform X8
AT-rich interaction domain 1A, transcript variant X2
AT-rich interaction domain 1A, transcript variant X1
AT-rich interactive domain-containing protein 1A isoform X1
AT-rich interactive domain-containing protein 1A isoform X2
phosphatidylinositol glycan anchor biosynthesis class V, transcript variant X3
phosphatidylinositol glycan anchor biosynthesis class V, transcript variant X1
phosphatidylinositol glycan anchor biosynthesis class V, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 18, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 18, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 18, transcript variant X3
GPN-loop GTPase 2, transcript variant X2
GPN-loop GTPase 2, transcript variant X1
nuclear receptor subfamily 0 group B member 2
nuclear distribution C, dynein complex regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
WD and tetratricopeptide repeats protein 1
synaptotagmin like 1, transcript variant X4
synaptotagmin like 1, transcript variant X7
synaptotagmin like 1, transcript variant X3
synaptotagmin like 1, transcript variant X5
synaptotagmin like 1, transcript variant X1
synaptotagmin like 1, transcript variant X2
synaptotagmin like 1, transcript variant X6
synaptotagmin like 1, transcript variant X8
CD164 molecule like 2, transcript variant X2
CD164 molecule like 2, transcript variant X1
CD164 molecule like 2, transcript variant X3
CD164 sialomucin-like 2 protein isoform X2
CD164 sialomucin-like 2 protein isoform X1
CD164 sialomucin-like 2 protein isoform X3
WASP family member 2, transcript variant X2
WASP family member 2, transcript variant X3
WASP family member 2, transcript variant X1
wiskott-Aldrich syndrome protein family member 2 isoform X2
wiskott-Aldrich syndrome protein family member 2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
LOW QUALITY PROTEIN: AT-hook DNA-binding motif-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
FGR proto-oncogene, Src family tyrosine kinase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tyrosine-protein kinase Fgr
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phosphatase and actin regulator 4, transcript variant X2
phosphatase and actin regulator 4, transcript variant X3
phosphatase and actin regulator 4 isoform X2
phosphatase and actin regulator 4, transcript variant X4
phosphatase and actin regulator 4, transcript variant X1
phosphatase and actin regulator 4 isoform X1
phosphatase and actin regulator 4 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
regulator of chromosome condensation 1, transcript variant X1
regulator of chromosome condensation 1, transcript variant X2
regulator of chromosome condensation isoform X1
regulator of chromosome condensation 1, transcript variant X4
regulator of chromosome condensation 1, transcript variant X3
regulator of chromosome condensation isoform X2
transcription elongation factor A3, transcript variant X1
transcription elongation factor A3, transcript variant X2
transcription elongation factor A protein 3 isoform X2
transcription elongation factor A protein 3 isoform X1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform X1
transcription factor E2F2-like, transcript variant X1
transcription factor E2F2-like, transcript variant X2
transcription factor E2F2-like isoform X1
transcription factor E2F2-like isoform X2